News from janssen A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

11 Sep, 2017, 06:24 BST Janssen to Discontinue Hepatitis C Development Program

Viral Hepatitis Research and Development to Focus on Addressing Significant Unmet Needs in Chronic Hepatitis B Janssen Sciences Ireland UC (Janssen), ...


04 Sep, 2017, 08:00 BST New Research Calls for More Open Treatment Discussions Between Psychiatrists and Their Patients Living With Schizophrenia

Janssen announces results of pan-European research which shows that a third of psychiatrists (34%) delay conversations about the full range of...


10 Oct, 2016, 08:00 BST New Survey Highlights Carers' Crucial Role with Adults Living with Schizophrenia

FOR EU TRADE AND MEDICAL MEDIA ONLY New pan-European survey commissioned by Janssen highlights the need for more education and open dialogue about...


14 Sep, 2016, 00:01 BST Trevicta® (paliperidone palmitate 3-monthly injection) Has Been Recommended by the Scottish Medicines Consortium (SMC) for Use in NHS Scotland Without Restriction for the Maintenance Treatment of Schizophrenia

PRESS RELEASE FOR MEDICAL AND TRADE MEDIA ONLY Janssen announced today that the Scottish Medicines Consortium (SMC) has accepted paliperidone...


18 Mar, 2016, 10:20 GMT STELARA® (ustekinumab) Induced Clinical Response and Remission in Phase 3 Study for the Treatment of Patients with Moderate to Severe Crohn's Disease Who Had Previously Failed or Were Intolerant to Anti-TNF-Alpha Therapy

Efficacy and safety results from second Phase 3 Induction Study (UNITI-1) in patients refractory to TNF Inhibitors, presented at the 11th European...


14 Sep, 2015, 09:00 BST A Strengthened Pharmaceutical R&D Investment Climate Will Help Address Health and Economic Challenges Confronting Europe

Continued research confirms growing economic and societal value of investment in health R&D. This can only be sustained through effective...


14 Sep, 2015, 00:01 BST Janssen's STELARA® (Ustekinumab) Available in the UK for the Treatment of Adolescents With Moderate-to-Severe Psoriasis

For trade and medical media only Launch of ustekinumab in adolescent psoriasis provides a new therapeutic option for plaque psoriasis patients aged...


17 Oct, 2014, 12:05 BST European Commission Approves IMBRUVICA™ in Two Forms of Blood Cancer

First-in-class BTK inhibitor for complex orphan diseases CLL and MCL Janssen-Cilag International NV (Janssen) announced today that the European...


08 Oct, 2014, 00:01 BST New Mental Health Integration Index Shows Europe Falls Short in Putting Aspirational Policies Into Practice

Better data, more funding and stronger focus on employment are among key recommendations from European experts Ahead of World Mental Health Day,...


25 Jul, 2014, 12:32 BST Janssen Receives Positive CHMP Opinion Recommending IMBRUVICA™ for use in the Treatment of Two Forms of Blood Cancer

Janssen-Cilag International NV (Janssen) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...


30 Jun, 2014, 12:30 BST Economist Intelligence Unit Report Calls for Urgent Global Action to Combat the Growing Tuberculosis Pandemic

A new report on tuberculosis (TB) published today by The Economist Intelligence Unit (EIU) investigates the increasing health challenges posed by TB...


24 Jun, 2014, 11:58 BST Fighting for Their Lives: Economist Intelligence Unit Report Finds Patient Groups Lead Global Efforts to Address Hepatitis C

New report calls on governments to play their part and improve surveillance, screening and diagnosis of hepatitis C worldwide 'Tackling hepatitis C:...


31 May, 2014, 12:31 BST Ibrutinib Three Year Follow-up of Single-Agent and Combination Study Results in Chronic Lymphocytic Leukemia

/NOT INTENDED FOR UK MEDIA/ Oral presentation (Abstract 7014) and poster session (Abstract 7009) featured at the 50th annual meeting of the American...


31 May, 2014, 12:31 BST Ibrutinib RESONATE(TM) Data Show Significant Improvements in Progression-Free Survival and Overall Survival in Patients with Relapsed/Refractory Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma Compared to ofatumumab

/FOR UK MEDICAL PRESS ONLY/ Phase 3 data (Abstract LBA7008) featured in the official press programme of the 50th annual meeting of the American...


31 May, 2014, 12:31 BST Ibrutinib RESONATE™ Data Show Significant Improvements in Progression-Free Survival and Overall Survival in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

/NOT INTENDED FOR UK MEDIA/ Phase 3 data (Abstract LBA7008) featured in the official press programme of the 50th annual meeting of the American...


09 Dec, 2013, 09:00 GMT Janssen, the Pharmaceutical Companies of Johnson & Johnson, Announces First-of-its-Kind Drug Donation Program for HIV Treatment-Experienced Children

Janssen, the pharmaceutical companies of Johnson & Johnson, today announced a first-of-its-kind pediatric HIV treatment donation program to improve...


29 Oct, 2013, 00:01 GMT 'Stop Hiding, Take Action!' - European Psoriasis Film Campaign Launched to Mark World Psoriasis Day

The European psoriasis film campaign Stop Hiding, Take Action! has been launched today - World Psoriasis Day - to raise awareness of the psychosocial ...


26 Apr, 2013, 11:04 BST INCIVO® Receives Positive Opinion from the Committee for Medicinal Products for Human Use (CHMP) for Twice Daily Dosing for Treatment of Genotype-1 Hepatitis C Virus

- OPTIMIZE study results presented at EASL show similar sustained virological response (SVR12) rates in patients with fibrosis or cirrhosis receiving ...


15 Jan, 2013, 10:51 GMT Economist Intelligence Unit Report Calls for Global Policy Innovation to Tackle the 'Silent Pandemic' That is Hepatitis C

- Experts recommend comprehensive approach to combat global health issue - A new Economist Intelligence Unit (EIU) report titled The Silent Pandemic: ...


15 Jan, 2013, 10:51 GMT Economist Intelligence Unit Report Calls for Global Policy Innovation to Tackle the 'Silent Pandemic' That is Hepatitis C

- Experts recommend comprehensive approach to combat global health issue - A new Economist Intelligence Unit (EIU) report titled The Silent Pandemic: ...


25 Jun, 2012, 11:25 BST VELCADE® erhält in der Europäischen Union eine positive Zulassungsempfehlung für die subkutane Verabreichung

ReportsnReports.com adds following new market research reports on Power Generation Costs as well as Grid Parity for Wind and Solar Power with a...


25 Jun, 2012, 11:14 BST VELCADE® Receives Positive Regulatory Recommendation in the European Union for Subcutaneous Administration

New route of administration provides improved safety and greater convenience for patients and healthcare professionals Janssen-Cilag International NV ...


15 Jun, 2012, 13:00 BST Janssen Submits Additional Marketing Applications for ZYTIGA® in the European Union and in the U.S.

 Simultaneous Submissions Based on Data from Pre-chemo Prostate Cancer Study Janssen-Cilag International NV announced today it has submitted a type...


09 Jun, 2012, 15:00 BST Canagliflozin Provided Substantial and Sustained Glycemic Improvements as Monotherapy and in Add-On Combinations in Adults with Type 2 Diabetes in Five Phase 3 Studies

Canagliflozin Provides Greater Reduction of A1C Levels in Adults with Type 2 Diabetes in 52-Week Head-to-Head Studies Compared to Sitagliptin and...


09 Jun, 2012, 15:00 BST Canagliflozin Provided Sustained Glycemic Improvements as Monotherapy and in Add-on Combinations in Adults With Type 2 Diabetes in Five Phase 3 Clinical Studies

Canagliflozin Provides Greater Reduction of A1C Levels in Adults with Type 2 Diabetes in 52-Week Head-to-Head Studies Compared to Sitagliptin and...